Pharma D-mand

Join us for Coriolis Pharma's webinar as we dive into the complexities of Adeno-associated viruses (AAVs), essential vectors in gene therapy development. This session will provide valuable insights for professionals facing manufacturing and analytical challenges with AAVs. November 20, 2024 4pm (CET) / 10am (ET) Learning objectives: ·      Explore analytical methods for AAV characterization during production ·      Understand essential quality attributes for high-quality AAV products ·      Discover techniques to measure AAV infectivity independently of therapeutic proteins Register now: https://lnkd.in/ebAMJRHc #AAV #GeneTherapy #Biotechnology #Webinar #Manufacturing

Join us on November 14th, 2024, for Stevanato Group’s webinar, where we’ll delve into how Ready-to-Use (RTU) solutions can assist in complying with the latest EU GMP Annex 1 requirements. Date: November 14th, 2024 Time: 4pm (CEST) / 10am (EDT) Webinar Highlights: ✔️ Learn how RTU containers reduce human intervention, minimizing potential risks of contamination ✔️ Understand how RTU solutions can simplify Contamination Control Strategy (CCS) ✔️ Explore ways to cut costs while maintaining high-quality and safety standards Don't miss out on this valuable opportunity to learn from industry experts and improve your operations. 🔗 Register now to secure your spot: https://lnkd.in/edQr97ms

Join Coriolis Pharma on November 20th, 2024, for their upcoming webinar on the manufacturing and analytical challenges of adeno-associated viruses (AAVs), a leading platform in gene therapy.   Key Learning Objectives: ·       Understand which analytical methods are best suited for AAV characterization. ·       Learn which quality attributes to monitor during AAV manufacturing. ·       Explore methods to measure AAV infectivity independently of the therapeutic protein. This is a great opportunity to enhance your expertise in AAV development Register here: https://lnkd.in/ebAMJRHc

How RTU Solutions Can Help You Meet GMP Annex 1 Requirements. With EU GMP Annex 1regulation requirements, pharmaceutical companies are facing increased pressure to reduce contamination risks and streamline manufacturing. Ready-to-Use (RTU) containers are emerging as a solution, automating key processes, reduce human intervention, minimizing potential risks of contamination. Join Stevanato Group’s webinar on November 14th, 2024 to learn the benefits for Pharma Companies of adopting RTU solutions: Register here: https://lnkd.in/edQr97ms

24 Hours to Go! Don’t Miss Nanopharm's Webinar on Inhaled & Nasal Drug Clinical Studies Join us tomorrow, October 22nd, 2024 at 4pm (CEST) / 10am (EST) for expert insights on how to accelerate your OINDP clinical development and minimize risks. Gemma Budd and Julie Suman are excited to share their knowledge on: • Balancing preparation levels in OINDP studies • Mitigating risks in CMC studies early in development • Navigating complex regulatory requirements for a smoother process A great chance to engage with the industry leaders. Register here: https://lnkd.in/eMGyN_AR

Paving the Way to a successful AAV Product! Mark your calendars for November 20th, 2024, at 4pm (CEST) / 10am (EDT) for an informative webinar addressing manufacturing and analytical challenges of AAVs.” Join Prof. Dr. Susumu Uchiyama from the University of Osaka and Dr. Melanie Schwerdtfeger from Coriolis Pharma as they delve into advanced analytical methods for AAV characterization. Prof. Uchiyama will outline key quality attributes critical during AAV manufacturing, while Dr. Schwerdtfeger will present case studies on measuring AAV infectivity and capsid ratios. Gain insights into optimizing your AAV product development process and ensuring high-quality outcomes! Register here: https://lnkd.in/ebAMJRHc #GeneTherapy #AAV #ProductDevelopment #Pharma #Webinar

1 Week Countdown! Join us on October 22nd, 2024, for Nanopharm's webinar, “Unlocking Success in Inhaled & Nasal Drug Clinical Studies.” This session will delve into the complexities of developing Orally Inhaled and Nasal Drug Products (OINDP). Our experts, Gemma Budd and Julie Suman, will discuss strategies to balance preparation, navigate regulatory landscapes, and mitigate risks in Chemistry, Manufacturing, and Controls (CMC) studies. Don’t miss this opportunity to enhance your understanding of OINDP development! Secure your spot here: https://lnkd.in/eMGyN_AR #Webinar #Pharma #InhaledDrugs #DrugDevelopment #ClinicalTrials

Unlock Key Insights in Stevanato Group’s Upcoming Webinar: "How RTU Solutions Can Meet GMP Annex 1 Requirements" November 14th, 2024 – 4pm (CEST) / 10am (EDT) With Ready-To-Use (RTU) containers, pharma companies can remove critical operating units and significantly automate their manufacturing process and reduce human intervention. Join us to discover how these pre-sterilized platforms can streamline your operations and enhance efficiency. Learning Objectives: ·      Compliance Simplified: Discover how RTU pre-sterilized platforms can help your company meet stringent EU GMP Annex 1 regulations. ·      Risk Reduction: Learn how RTU solutions support de-risking operations throughout the manufacturing process, minimizing contamination risks and enhancing safety. ·      Cost Efficiency: Understand how outsourcing production processes to experienced partners can reduce total costs and streamline non-core activities. Don’t miss this chance to gain valuable knowledge and improve your manufacturing strategy! Register now to secure your spot: https://lnkd.in/edQr97ms #Pharma #RTUSolutions #GMPAnnex1 #AsepticManufacturing #Webinar #PharmaceuticalInnovation #Compliance #CostEfficiency

Facing AAV Manufacturing and Analytical Challenges? Adeno-associated viruses (AAVs) are pivotal in gene therapy, but manufacturing and analysis complexities can impede progress. Are you encountering these issues? ·      Heterogeneity in “full particles”: Understand the sources of variability in your samples. ·      Choosing the right biophysical method: Determine which technique fits your sample quality and quantity and recognize their limitations. ·      Method adaptation for developmental stages: Learn how to apply different analytical methods throughout the AAV vector development process. Join Prof. Dr. Susumu Uchiyama and Dr. Melanie Schwerdtfeger as they address these challenges and share real-world solutions. Date: November 20th, 2024 – 4pm (CEST) / 10am (EDT) Register here: https://lnkd.in/ebAMJRHc #AAV #GeneTherapy #PharmaWebinar #Biotech #DrugDevelopment #AnalyticalMethods

Don’t Miss Out on Nanopharms upcoming webinar ‘Unlocking Success in Inhaled & Nasal Drug Clinical Studies’ Gain crucial insights into accelerating and derisking your OINDP clinical studies. What You’ll Learn: ·      Balancing preparation levels in OINDP clinical studies to avoid delays and inflated costs ·      Mitigating risks early in Chemistry, Manufacturing, and Controls (CMC) studies ·      Navigating regulatory expectations for smooth and efficient development Our experts, Gemma Budd and Julie Suman, will guide you through the complex pathways of clinical studies and share strategies that can keep your project on track. Date: October 22nd, 2024 Time: 4pm (CEST) / 10am (EST) Register here: https://lnkd.in/eMGyN_AR #PharmaWebinar #OINDP #DrugDevelopment #RegulatoryAffairs #RiskManagement #CMC #Innovation